BOSTON--(BUSINESS WIRE)--Emulate, Inc. announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Food and Drug Administration’s (FDA) Office of ...
Boston-based Emulate and the U.S. Food & Drug Administration’s Office of Foods and Veterinary Medicine have inked a Cooperative Research and Development Agreement (CRADA) to advance the company’s ...
BOSTON--(BUSINESS WIRE)--Emulate, Inc., a leading provider of next generation in vitro models, today announced the close of an $82 million Series E financing round led by existing investor Northpond ...
Emulate said today it will partner with the FDA to evaluate and qualify the company’s Organs-on-Chips technology for toxicology testing to meet regulatory standards for products that include foods, ...
On March 9, 2023, Emulate will celebrate Global Microphysiological Systems Day by bringing together key opinion leaders from industry, academia, and government to discuss the future of MPS and ...
After becoming its first big pharma partner several years ago, AstraZeneca has given Emulate a major seal of approval by embedding its ‘organs on a chip’ technology into its own research team. Each of ...
BOSTON, Dec. 21, 2020 /PRNewswire/ -- Emulate, Inc., a leading provider of advanced in vitro models, today unveiled the Emulate Brain-Chip, which is designed for neuroscience researchers investigating ...
Emulate, Inc., a leading provider of next-generation in vitro models, today announced that the Brain-Chip is being sent to the International Space Station U.S. National Laboratory (ISS National Lab) ...
BOSTON, Dec. 21, 2020 /PRNewswire/ -- Emulate, Inc., a leading provider of advanced in vitro models, today unveiled the Emulate Brain-Chip, which is designed for neuroscience researchers investigating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback